Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Adverse Effects: early-phase trial registry
1 of 4 indexed Adverse Effects trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Adverse Effects: 4 US clinical trials tracked, 1 recruiting.
Adverse Effects is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is John Levine, running 2 of these trials.
Enrollment posture brief
Registry condition adverse-effects
OPEN 1 | RECR 25% | LATE 0 | EARLY 3 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Adverse Effects lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Adverse Effects on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Adverse Effects is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
MAGIC Ruxolitinib for aGVHD
John Levine
NCT06936566
Pediatric GVHD Low Risk Steroid Taper Trial
John Levine
NCT05090384
Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week
St. Luke's-Roosevelt Hospital Center
NCT01881776
Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
Duquesne University
NCT00696839
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Adverse Effects records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Adverse Effects trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Adverse Effects page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Adverse Effects trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- John Levine sponsors the most Adverse Effects trials on record, review their full trial history before evaluating a specific study. See John Levine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adverse Effects condition card totals 4 registered trials; most-linked intervention Cognitive-behavioral therapy; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.